Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of Fufangdanshen Tablets in mild to moderate vascular dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fufangdanshen Tablets

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Vascular Dementia | Phase 2 | Status: COMPLETED